Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 7.01, 9.01 · 8-K

PERRIGO COMPANY PLC

PRGONYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 2, 2025, Ronald Janish and Perrigo Company plc (“Perrigo” or the “Company”) reached mutual agreement regarding his planned retirement. As agreed, Mr.…

Filed Jun 4, 2025Accepted Jun 4, 2025, 4:54 PM EDTCIK 1585364Accession 0001193125-25-134980
Share

Company context

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Current securities

Recent company filings

  1. 10-Q filingNov 4, 2026
  2. Results of Operations and Financial ConditionNov 4, 2026
  3. Regulation FD DisclosureOct 29, 2026
  4. 4 filingSep 15, 2026
  5. 4 filingSep 15, 2026

Disclosure sections

Items 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 2, 2025, Ronald Janish and Perrigo Company plc (“Perrigo” or the “Company”) reached mutual agreement regarding his planned retirement. As agreed, Mr. Janish will step down from his current position as Executive Vice President, Global Operations and Supply Chain of the Company, effective June 23, 2025. Following such date, Mr. Janish will continue in an advisory capacity until September 30, 2025. Subject to a general release of claims and other applicable obligations, upon his separation from the Company, Mr. Janish will be entitled to a lump sum severance payment equal to 2.5 times his base salary and target annual bonus and statutory redundancy payments under the Company’s Irish Severance Programme, as well as continued vesting of his equity awards pursuant to his employment agreement. The foregoing summary is qualified in its entirety by reference to Mr. Janish’s compromise waiver agreement, a copy of which is attached hereto as Exhibit 10.1.
Item 7.01Item 7.01 - Regulation FD Disclosure
ITEM 7.01. Regulation FD Disclosure On June 4, 2025, Perrigo announced the appointment of Matt Winterman as Executive Vice President of Global Operations and Supply Chain, effective June 23, 2025. Mr. Winterman brings more than 20 years of global supply chain and strategy leadership to Perrigo. Most recently, he served as SVP of Global Supply Chain and Strategy at AstraZeneca, overseeing a $54 billion supply chain across 5,000 SKUs. In this capacity, he was instrumental in driving transformation and strategic investment in the manufacturing network. He also served as Global Head of end-to-end Supply Chain at Roche Holding AG, and in roles of increasing responsibility for technical operations strategy and supply chain performance at GSK plc. Mr. Winterman graduated with a Bachelor of Science degree in Economics from the University of Bristol. On June 4, 2025, Perrigo issued a press release announcing Mr. Janish’s retirement and Mr. Winterman’s appointment, a copy of which is attached hereto as Exhibit 99.1. Perrigo undertakes no obligation to update, supplement or amend the press release attached hereto as Exhibit 99.1. The information in Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) d932694dex991.htm

EX-99.1 3 d932694dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Perrigo Announces Global Operations and Supply Chain Leadership Transition Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer Dublin, Ireland - June 4, 2025 - Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Matt Winterman as Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, effective June 23, 2025. Mr. Winterman succeeds Ron Janish, who will retire from the Company on September 30, 2025, following a distinguished career at Perrigo spanning more than two decades. Both executives will closely work together to ensure a smooth transition. Throughout his tenure, Mr. Janish played an integral role in advancing and aligning the Company’s supply chain with its transformation to a consumer self-care leader and steering its Supply Chain Reinvention program, which significantly reduced portfolio complexity and improved forecast accuracy. His leadership was especially impactful during the COVI…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.